Alexion Pharmaceuticals, Inc
Alexion Pharmaceuticals, Inc. is dedicated to transforming the lives of people affected by rare diseases through continuous innovation and meaningful value creation. As part of AstraZeneca, they focus on developing breakthrough therapies, advancing science, and improving health equity for the rare disease community worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Alexion Pharmaceuticals, Inc
Cheshire, Connecticut, United States, North America
Products
Commercial and investigational medicines for rare diseases
Prescription medicines and investigational therapeutic candidates developed to treat rare diseases across hematology, nephrology, neurology, metabolic disorders, endocrinology, cardiology and bone metabolism.
Commercial and investigational medicines for rare diseases
Prescription medicines and investigational therapeutic candidates developed to treat rare diseases across hematology, nephrology, neurology, metabolic disorders, endocrinology, cardiology and bone metabolism.
Services
Patient-centric clinical trial design and execution
Design and conduct of clinical studies that integrate patient engagement, patient-focused metrics and strategies to improve accessibility and scientific rigor.
Managed access (compassionate use) program administration
Assessment and processing of unsolicited physician requests for access to investigational medicines under country-specific regulatory frameworks.
Externally sponsored research and investigator collaboration support
Guidance and administrative support for investigator-sponsored research and externally sponsored collaborations, including submission pathways and evaluation criteria.
Discovery partnership and preclinical collaboration
Partnerships with academia, research hospitals and biotech to support preclinical translation, target identification, biomarker work and novel delivery method evaluation.
Data science and AI services for R&D and diagnostics
Application of algorithms and analytics to accelerate discovery, analyze clinical and diagnostic data, and support diagnostic pathway improvements.
Medical information, safety reporting and product complaint handling
Provision of medical information responses and formal channels for adverse event reporting and product issue submission.
Patient-centric clinical trial design and execution
Design and conduct of clinical studies that integrate patient engagement, patient-focused metrics and strategies to improve accessibility and scientific rigor.
Managed access (compassionate use) program administration
Assessment and processing of unsolicited physician requests for access to investigational medicines under country-specific regulatory frameworks.
Externally sponsored research and investigator collaboration support
Guidance and administrative support for investigator-sponsored research and externally sponsored collaborations, including submission pathways and evaluation criteria.
Discovery partnership and preclinical collaboration
Partnerships with academia, research hospitals and biotech to support preclinical translation, target identification, biomarker work and novel delivery method evaluation.
Data science and AI services for R&D and diagnostics
Application of algorithms and analytics to accelerate discovery, analyze clinical and diagnostic data, and support diagnostic pathway improvements.
Medical information, safety reporting and product complaint handling
Provision of medical information responses and formal channels for adverse event reporting and product issue submission.
Expertise Areas
- Rare disease research and development
- Clinical trial management for rare diseases
- Genomics and genetic diagnostics
- Data science and AI for drug discovery and diagnostics
Key Technologies
- Artificial intelligence and machine learning
- Next-generation sequencing
- Digital health technologies
- Real-world evidence analytics